- Home
- MTLS vs EBS Comparison
MTLS vs EBS Comparison
Compare MTLS & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTLS
- EBS
- Stock Information
- Founded
- MTLS 1990
- EBS 1998
- Country
- MTLS Belgium
- EBS United States
- Employees
- MTLS N/A
- EBS N/A
- Industry
- MTLS Computer Software: Prepackaged Software
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- MTLS Technology
- EBS Health Care
- Exchange
- MTLS Nasdaq
- EBS Nasdaq
- Market Cap
- MTLS 467.2M
- EBS 518.0M
- IPO Year
- MTLS 2014
- EBS 2006
- Fundamental
- Price
- MTLS $7.87
- EBS $10.20
- Analyst Decision
- MTLS Buy
- EBS Strong Buy
- Analyst Count
- MTLS 1
- EBS 3
- Target Price
- MTLS $9.50
- EBS $14.33
- AVG Volume (30 Days)
- MTLS 184.2K
- EBS 1.1M
- Earning Date
- MTLS 02-19-2025
- EBS 03-04-2025
- Dividend Yield
- MTLS N/A
- EBS N/A
- EPS Growth
- MTLS 323.01
- EBS N/A
- EPS
- MTLS 0.19
- EBS N/A
- Revenue
- MTLS $297,100,156.00
- EBS $1,125,500,000.00
- Revenue This Year
- MTLS $8.48
- EBS $6.26
- Revenue Next Year
- MTLS $9.65
- EBS $2.42
- P/E Ratio
- MTLS $40.29
- EBS N/A
- Revenue Growth
- MTLS 5.07
- EBS 2.05
- 52 Week Low
- MTLS $4.70
- EBS $1.42
- 52 Week High
- MTLS $8.50
- EBS $15.10
- Technical
- Relative Strength Index (RSI)
- MTLS 55.05
- EBS 60.60
- Support Level
- MTLS $7.55
- EBS $9.20
- Resistance Level
- MTLS $8.10
- EBS $10.63
- Average True Range (ATR)
- MTLS 0.41
- EBS 0.67
- MACD
- MTLS 0.02
- EBS 0.05
- Stochastic Oscillator
- MTLS 74.59
- EBS 81.86
About MTLS Materialise NV
Materialise NV is a provider of 3D printing services. The products and services of the group are organized in three segments: Medical segment, which develops and delivers medical software solutions, medical devices, and other related products and services; Software segment, which develops and delivers additive manufacturing software solutions and related services; and Manufacturing segment, which delivers 3D printed products and related services. Its geographical segments are the United States, the Americas (excluding the USA), Belgium, Germany, Poland, France, Switzerland, the United Kingdom, Italy, the Netherlands, Other Europe, and the Asia Pacific.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.